Ausgabe 1/2021
Inhalt (9 Artikel)
Inhibitors of Src Family Kinases, Inducible Nitric Oxide Synthase, and NADPH Oxidase as Potential CNS Drug Targets for Neurological Diseases
Meghan C. Gage, Thimmasettappa Thippeswamy
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Christoph U. Correll, Edward Kim, Jennifer Kern Sliwa, Wayne Hamm, Srihari Gopal, Maju Mathews, Raja Venkatasubramanian, Stephen R. Saklad
Expanding the Treatment Landscape for Lennox-Gastaut Syndrome: Current and Future Strategies
Adam Strzelczyk, Susanne Schubert-Bast
Safety and Efficacy of Sovateltide (IRL-1620) in a Multicenter Randomized Controlled Clinical Trial in Patients with Acute Cerebral Ischemic Stroke
Anil Gulati, Nilesh Agrawal, Deepti Vibha, U. K. Misra, Birinder Paul, Dinesh Jain, Jeyaraj Pandian, Rupam Borgohain
Efficacy and Safety of Ibuprofen Plus Paracetamol in a Fixed-Dose Combination for Acute Postoperative Pain in Adults: Meta-Analysis and a Trial Sequential Analysis
Dina Abushanab, Daoud Al-Badriyeh
Correction to: Siponimod: A Review in Secondary Progressive Multiple Sclerosis
Lesley J. Scott
Correction to: OnabotulinumtoxinA in Chronic Migraine: A Profile of Its Use
James E. Frampton